Complicated Clostridium difficile colitis in children with cystic fibrosis: Association with gastric acid suppression?

Journal of Cystic Fibrosis

Volumn 13, Issue 1, 2014, Pages 37-42

  Com, G ^a   Cetin, N ^b   O'Brien, C E ^b,c  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Department of Pharmacology   (United States)

Author keywords

Acid blockers; Clostridium difficile; Cystic fibrosis; Diarrhea; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; METRONIDAZOLE; PROTON PUMP INHIBITOR; VANCOMYCIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADOLESCENT; ARTICLE; ASCITES; BACTERIAL COLONIZATION; BLOODY DIARRHEA; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DIARRHEA; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL REFLUX; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; ILEOSTOMY; INFANT; LAPAROTOMY; LUNG FUNCTION; MALE; MORBIDITY; NUTRITIONAL STATUS; RETROPERITONEAL HEMORRHAGE; SCHOOL CHILD; STOMACH ACID; TOTAL COLON RESECTION; VOMITING;

ACID BLOCKERS; CLOSTRIDIUM DIFFICILE; CYSTIC FIBROSIS; DIARRHEA; PROTON PUMP INHIBITORS;

ADOLESCENT; ANTACIDS; BIOPSY; CHILD; CLOSTRIDIUM DIFFICILE; COLON; CYSTIC FIBROSIS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ESOMEPRAZOLE; FATAL OUTCOME; FEMALE; GASTRIC ACID; HUMANS; INFANT; MALE; MEGACOLON, TOXIC; PROTON PUMP INHIBITORS; RISK FACTORS;

EID: 84890435928     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.08.005     Document Type: Article

References (34)

1. Kelly C.P., LaMont J.T. Clostridium difficile - more difficult than ever. N Engl J Med 2008, 359(18):1932-1940.
2. Kato H., Kita H., Karasawa T., Maegawa T., Koino Y., Takakuwa H., et al. Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol 2001, 50(8):720-727.
3. Theunissen C., Knoop C., Nonhoff C., Byl B., Claus C., Liesnard C., et al. Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation. Transpl Infect Dis 2008, 10:240-244.
4. Turco R., Martinelli M., Miele E., Roscetto E., Del Pezzo M., Greco L., et al. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther 2010, 31:754-759.
5. Dial S., Alrasadi K., Manoukian C., Huang A., Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004, 171(1):33-38.
6. Dial S., Chris Delaney J.A., Schneider V., Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ 2006, 175(7):745-748.
7. Dial S., Delaney J.A.C., Barkun A.N., Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005, 294(23):2989-2995.
8. Cunningham R., Dale B., Undy B., Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003, 54(3):243-245.
9. Yearsley K.A., Gilby L.J., Ramadas A.V., Kubiak E.M., Fone D.L., Allison M.C. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment Pharmacol Ther 2006, 24:613-619.
10. Aseeri M., Schroeder T., Kramer J., Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 2008, 103:2308-2313.
11. Proesmans M., De Boeck K. Omeprazole, a proton pump inhibitor, improves residual steatorrhea in cystic fibrosis patients treated with high dose pancreatic enzymes. Eur J Pediatr 2003, 162:760-763.
12. Patient Registry Annual Data Report 2011, Cystic Fibrosis Foundation2012, Bethesda, MD.
13. Egressy K., Jansen M., Meyer K.C. Recurrent Clostridium difficile colitis in cystic fibrosis: an emerging problem. J Cyst Fibros 2013, 12(1):92-96.
14. Rivlin J., Lerner A., Augarten A., Wilschanski M., Kerem E., Ephros M.A. Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. J Pediatr 1998, 132(1):177-179.
15. Rosen J.B., Schecter M.G., Heinle J.S., McKenzie E.D., Morales D.L., Dishop M.K., et al. Clostridium difficile colitis in children following lung transplantation. Pediatr Transplant 2010, 14:651-656.
16. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society fo America (IDSA). Infect Control Hosp Epidemiol 2010, 31(5):431-455.
17. Chitnis A.S., Holzbauer S.M., Belflower R.M., Winston L.G., Bamberg W.M., Lyons C., et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through. JAMA Intern Med 2011, 2013:1-9.
18. Peach S.L., Borrielo S.P., Gaya H., Barclay F.E., Welch A.R. Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis. J Clin Pathol 1986, 39:1013-1018.
19. DISEASES C.O.I. Policy statement: Clostridium difficile infection in infants and children. Pediatrics 2013, 131(1):196-200.
20. DeLisle S., Meldi L., Roach E., Flynn M., Sewell R. Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse. PLoS One 2009, 4(1):e4283.
21. De Lisle R.C., Mueller R., Boyd M. Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse. J Pediatr Gastroenterol Nutr 2011, 53(4):371-379.
22. De Lisle R.C., Sewell R., Meldi L. Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine. Neurogastroenterol Motil 2010, 22:341-e87.
23. Werlin S.L., Benuri-Silbiger I., Kerem E., Adler S.N., Goldin E., Zimmerman J., et al. Evidence of intestinal inflammation in patients with cystic fibrosis. JPGN 2010, 51(3):304-308.
24. Howell M.D., Novack V., Grgurich P., Soulliard D., Novack L., Pencina M., et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010, 170(9):784-790.
25. Kwok C.S., Arthur A.K., Anibueze C.I., Singh S., Cavallazzi R., Loke Y.K. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012, 107:1011-1019.
26. Janarthanan S., Ditah I., Adler D.G., Ehrinpreis M.N. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012, 107:1001-1010.
27. Pauwels A., Blondeau K., Dupont L.J., Sifrim D. Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis. Am J Gastroenterol 2012, 107:1346-1353.
28. Ahmed N., Corey M., Forstner G., Zielenski J., Tsui L.C., Ellis L., et al. Molecular consequences fo cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 2003, 52(8):1159-1164.
29. Francisco M.P., Wagner M.H., Sherman J.M., Theriaque D., Bowser E., Novak D.A. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002, 35(1):79-83.
30. Proesmans M., De Boeck K. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes. Eur J Pediatr Nov 2003, 162(11):760-763. [Epub 2003 Sep 17].
31. Ng S.M., Francini A.J. Drug therapies for reducing gastric acidity in people with cystic fibrosis. Cochrane Database Syst Rev 2012, 4:CD003424.
32. Johnson S., Gerding D.N. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998, 26(5):1027-1034.
33. Thomas D.W., Greer F.R. Clinical report - probiotics and prebiotics in pediatrics. Pediatrics 2010, 126:1217-1231.
34. Rea M.C., Alemayehu D., Ross R.P., Hill C. Gut Solutions to a Gut Problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection. J Med Microbiol May 2013, 22. [Epub ahead of print].